IGHV1-8 |
P0DP01
|
immunoglobulin heavy variable 1-8
|
|
|
1.000 |
0.115 |
DLEU2L |
|
deleted in lymphocytic leukemia 2 like
|
|
0.37 |
1.000 |
0.115 |
DOHH |
Q9BU89
|
deoxyhypusine hydroxylase
|
|
1.6E-02 |
0.743 |
0.154 |
FBXO10 |
Q9UK96
|
F-box protein 10
|
|
2.4E-06 |
0.861 |
0.154 |
SH3YL1 |
Q96HL8
|
SH3 and SYLF domain containing 1
|
Cellular structure
|
5.4E-08 |
0.931 |
0.154 |
RGS18 |
Q9NS28
|
regulator of G protein signaling 18
|
Enzyme modulator
|
1.5E-03 |
0.861 |
0.154 |
ROR1-AS1 |
|
ROR1 antisense RNA 1
|
|
|
0.751 |
0.192 |
MLSM7 |
|
Myelodysplasia and leukemia syndrome with monosomy 7
|
|
|
0.743 |
0.192 |
IGHV3-21 |
A0A0B4J1V1
|
immunoglobulin heavy variable 3-21
|
|
|
0.780 |
0.192 |
MOB3A |
Q96BX8
|
MOB kinase activator 3A
|
Enzyme modulator
|
2.9E-05 |
0.931 |
0.192 |
ABCA6 |
Q8N139
|
ATP binding cassette subfamily A member 6
|
Transporter
|
5.1E-27 |
0.861 |
0.231 |
TUBGCP3 |
Q96CW5
|
tubulin gamma complex associated protein 3
|
Cellular structure
|
0.46 |
0.780 |
0.231 |
MIR92A1 |
|
microRNA 92a-1
|
|
|
0.769 |
0.269 |
FBXO25 |
Q8TCJ0
|
F-box protein 25
|
|
2.0E-04 |
0.839 |
0.269 |
MEF2B |
Q02080
|
myocyte enhancer factor 2B
|
|
9.3E-04 |
0.670 |
0.308 |
CD5 |
P06127
|
CD5 molecule
|
|
2.3E-10 |
0.682 |
0.308 |
RAD51AP1 |
Q96B01
|
RAD51 associated protein 1
|
|
1.1E-02 |
0.705 |
0.308 |
IGHV4-34 |
P06331
|
immunoglobulin heavy variable 4-34
|
|
|
0.716 |
0.308 |
MS4A4A |
Q96JQ5
|
membrane spanning 4-domains A4A
|
Receptor
|
8.1E-06 |
0.722 |
0.308 |
FCRL1 |
Q96LA6
|
Fc receptor like 1
|
Cell adhesion
|
4.0E-06 |
0.751 |
0.308 |
RAB35 |
Q15286
|
RAB35, member RAS oncogene family
|
|
0.98 |
0.780 |
0.308 |
TUBGCP4 |
Q9UGJ1
|
tubulin gamma complex associated protein 4
|
Cellular structure
|
3.7E-09 |
0.716 |
0.346 |
HDAC10 |
Q969S8
|
histone deacetylase 10
|
Epigenetic regulator
|
3.0E-31 |
0.695 |
0.346 |
IGHD |
P01880
|
immunoglobulin heavy constant delta
|
|
|
0.722 |
0.346 |
GNAZ |
P19086
|
G protein subunit alpha z
|
Enzyme modulator
|
0.96 |
0.722 |
0.346 |